• LAST PRICE
    56.9900
  • TODAY'S CHANGE (%)
    Trending Down-1.9600 (-3.3249%)
  • Bid / Lots
    56.9400/ 2
  • Ask / Lots
    57.1000/ 4
  • Open / Previous Close
    58.7300 / 58.9500
  • Day Range
    Low 56.9900
    High 59.8200
  • 52 Week Range
    Low 42.2100
    High 76.9800
  • Volume
    635,362
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 58.95
TimeVolumeIMCR
09:32 ET292258.8002
09:34 ET133059.12
09:36 ET50059
09:38 ET10058.86
09:39 ET50059
09:41 ET30059
09:43 ET135958.9513
09:45 ET158159
09:48 ET120059
09:52 ET80059
09:54 ET10058.96
09:56 ET240058.965
09:59 ET130358.9825
10:01 ET240058.73
10:03 ET40059
10:06 ET70059.01
10:10 ET90058.89
10:12 ET29458.9
10:14 ET228759
10:15 ET520059
10:17 ET30058.965
10:21 ET480058.96
10:24 ET736159.11
10:26 ET219359.18
10:28 ET42961059.645
10:30 ET54059.56
10:33 ET40059.665
10:35 ET383459.55
10:37 ET45059.2
10:39 ET82259.06
10:44 ET30058.995
10:50 ET20058.9
10:53 ET10258.8
10:55 ET76158.58
10:57 ET80058.74
11:00 ET160258.65
11:02 ET40058.73
11:04 ET80058.64
11:06 ET60058.67
11:08 ET120058.58
11:09 ET90958.535
11:11 ET172858.535
11:13 ET146058.53
11:15 ET142558.4
11:20 ET30258.365
11:22 ET100058.32
11:24 ET82558.5
11:26 ET190358.39
11:27 ET50058.405
11:29 ET30058.445
11:31 ET130058.33
11:33 ET122558.35
11:36 ET56658.35
11:40 ET10058.385
11:44 ET150058.345
11:45 ET70058.34
11:47 ET30058.385
11:49 ET62058.32
11:51 ET129658.245
11:54 ET70058.205
11:56 ET90058.18
11:58 ET50058.21
12:00 ET50058.12
12:02 ET45058.21
12:03 ET30058.1
12:05 ET30058.157
12:07 ET37558.1692
12:09 ET244458.29
12:12 ET36058.41
12:16 ET70058.36
12:20 ET20058.405
12:23 ET135258.535
12:25 ET100458.465
12:27 ET100058.47
12:30 ET110058.51
12:32 ET112358.36
12:34 ET100058.31
12:36 ET80058.29
12:38 ET72458.15
12:39 ET102258.16
12:41 ET40058.15
12:43 ET60058.08
12:45 ET100058.12
12:48 ET72558.12
12:52 ET33058.12
12:56 ET42858.12
12:57 ET59058.12
12:59 ET111158.09
01:01 ET737057.91
01:03 ET262557.98
01:06 ET67258
01:08 ET10058
01:10 ET10057.9
01:14 ET35057.94
01:17 ET10057.95
01:24 ET20058.055
01:28 ET50057.99
01:30 ET30057.94
01:32 ET20057.94
01:33 ET138658.01
01:35 ET50057.95
01:37 ET10057.97
01:42 ET20058.025
01:46 ET10057.97
01:48 ET40058.01
01:50 ET470857.97
01:51 ET535257.9
01:53 ET30057.92
01:55 ET30057.9
01:57 ET20057.86
02:00 ET80057.85
02:02 ET40057.69
02:04 ET80057.795
02:06 ET30057.81
02:08 ET73857.93
02:09 ET10057.89
02:11 ET10057.935
02:13 ET30057.935
02:18 ET10057.95
02:20 ET94357.88
02:22 ET10057.91
02:24 ET120057.905
02:26 ET40057.88
02:27 ET100057.81
02:29 ET30057.77
02:31 ET170257.76
02:33 ET90057.755
02:36 ET70057.765
02:38 ET10057.82
02:40 ET34057.745
02:42 ET191157.58
02:44 ET10057.55
02:45 ET91957.535
02:47 ET30057.545
02:49 ET192057.57
02:51 ET20057.54
02:54 ET172757.48
02:56 ET137357.435
03:00 ET30057.34
03:02 ET40057.27
03:03 ET81257.25
03:05 ET82957.25
03:09 ET63257.25
03:12 ET56457.295
03:14 ET110057.24
03:16 ET40057.14
03:18 ET196957.22
03:20 ET127157.06
03:21 ET47757.035
03:23 ET74457.03
03:25 ET191657
03:27 ET100056.97
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMCR
Immunocore Holdings PLC
2.9B
-50.4x
---
United StatesCORT
Corcept Therapeutics Inc
2.8B
26.1x
+9.80%
United StatesLGND
Ligand Pharmaceuticals Inc
1.6B
16.1x
-12.71%
United StatesINVA
Innoviva Inc
975.3M
7.4x
-9.89%
United StatesEOLS
Evolus Inc
798.3M
-12.1x
---
United StatesAVDL
Avadel Pharmaceuticals PLC
1.6B
-9.2x
---
As of 2024-05-13

Company Information

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Contact Information

Headquarters
90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
Phone
123-543-8600
Fax
---

Executives

Independent Chairman of the Board
John Bell
Chief Executive Officer, Director
Bahija Jallal
Chief Financial Officer, Head of Strategy
Brian Di Donato
Chief Human Resource Officer
Tina St Leger
Head of Research and Development
David Berman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.9B
Revenue (TTM)
$249.4M
Shares Outstanding
50.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.13
Book Value
$7.42
P/E Ratio
-50.4x
Price/Sales (TTM)
11.8
Price/Cash Flow (TTM)
---
Operating Margin
-23.91%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.